Taylor R - Search Results

1

Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.

Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Zimrin A, Strome S, Regine W, Suntharalingam M. Strongin A, et al. Among authors: taylor r. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1823-30. doi: 10.1016/j.ijrobp.2010.10.053. Epub 2011 May 5. Int J Radiat Oncol Biol Phys. 2012. PMID: 21549516

2

Lactoferrin inhibits growth of malignant tumors of the head and neck.

Wolf JS, Li D, Taylor RJ, O'Malley BW Jr. Wolf JS, et al. ORL J Otorhinolaryngol Relat Spec. 2003 Sep-Oct;65(5):245-9. doi: 10.1159/000075220. ORL J Otorhinolaryngol Relat Spec. 2003. PMID: 14730178

3

The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).

Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R. Suntharalingam M, et al. Among authors: taylor r. Semin Oncol. 2004 Dec;31(6 Suppl 18):2-7. doi: 10.1053/j.seminoncol.2005.02.001. Semin Oncol. 2004. PMID: 15726515 Clinical Trial.

4

Informed consent in endoscopic sinus surgery: the patient perspective.

Wolf JS, Chiu AG, Palmer JN, O'Malley BW Jr, Schofield K, Taylor RJ. Wolf JS, et al. Laryngoscope. 2005 Mar;115(3):492-4. doi: 10.1097/01.mlg.0000157835.69121.f8. Laryngoscope. 2005. PMID: 15744164

5

Inflammatory myofibroblastic tumor of the larynx in a 2-year-old male.

Rodrigues M, Taylor RJ, Sun CC, Wolf JS. Rodrigues M, et al. ORL J Otorhinolaryngol Relat Spec. 2005;67(2):101-5. doi: 10.1159/000084997. Epub 2005 Apr 8. ORL J Otorhinolaryngol Relat Spec. 2005. PMID: 15821353 Review.

6

Informed consent in sinus surgery: link between demographics and patient desires.

Taylor RJ, Chiu AG, Palmer JN, Schofield K, O'Malley BW Jr, Wolf JS. Taylor RJ, et al. Laryngoscope. 2005 May;115(5):826-31. doi: 10.1097/01.MLG.0000157333.40429.72. Laryngoscope. 2005. PMID: 15867648

7

Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo.

Wolf JS, Li G, Varadhachary A, Petrak K, Schneyer M, Li D, Ongkasuwan J, Zhang X, Taylor RJ, Strome SE, O'Malley BW Jr. Wolf JS, et al. Clin Cancer Res. 2007 Mar 1;13(5):1601-10. doi: 10.1158/1078-0432.CCR-06-2008. Clin Cancer Res. 2007. PMID: 17332307 Free PMC article.

8

Elevated expression of glutathione S-transferase pi and p53 confers poor prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy alone.

Schumaker L, Nikitakis N, Goloubeva O, Tan M, Taylor R, Cullen KJ. Schumaker L, et al. Among authors: taylor r. Clin Cancer Res. 2008 Sep 15;14(18):5877-83. doi: 10.1158/1078-0432.CCR-08-0998. Clin Cancer Res. 2008. PMID: 18794100 Free PMC article.

9

FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck.

Taylor RJ, Chan SL, Wood A, Voskens CJ, Wolf JS, Lin W, Chapoval A, Schulze DH, Tian G, Strome SE. Taylor RJ, et al. Cancer Immunol Immunother. 2009 Jul;58(7):997-1006. doi: 10.1007/s00262-008-0613-3. Epub 2008 Nov 1. Cancer Immunol Immunother. 2009. PMID: 18979096 Free PMC article.

10

Epitope mapping of a chimeric CD137 mAb: a necessary step for assessing the biologic relevance of non-human primate models.

Chan SL, Voskens CJ, Lin W, Schindler DG, Azimzadeh A, Wang LX, Taylor RJ, Strome SE, Schulze DH. Chan SL, et al. J Mol Recognit. 2009 May-Jun;22(3):242-9. doi: 10.1002/jmr.937. J Mol Recognit. 2009. PMID: 19177494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,134 results

Search Page

Filters